EdgarLookup

Shimmick Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Shimmick Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-5.2%
Profit Margin
Net income ÷ revenue
-11.7%
Return on Assets
Net income ÷ assets
+2.6%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $492.84M Mar 13, 2026
FY2025 Jan 3, 2025 $480.24M Mar 13, 2026
FY2025 Dec 29, 2023 $632.81M Mar 20, 2025
FY2023 Dec 30, 2022 $664.16M Mar 28, 2024

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $33.59M Mar 13, 2026
FY2025 Jan 3, 2025 ($55.65M) Mar 13, 2026
FY2025 Dec 29, 2023 $22.37M Mar 20, 2025
FY2023 Dec 30, 2022 $23.52M Mar 28, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 ($25.58M) Mar 13, 2026
FY2025 Jan 3, 2025 ($124.75M) Mar 13, 2026
FY2025 Dec 29, 2023 ($2.55M) Mar 20, 2025
FY2023 Dec 30, 2022 $3.76M Mar 28, 2024

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 ($19.40M) Mar 13, 2026
FY2025 Jan 3, 2025 ($119.33M) Mar 13, 2026
FY2025 Dec 29, 2023 $435.0K Mar 20, 2025
FY2023 Dec 30, 2022 $12.91M Mar 28, 2024

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $54.58M Mar 13, 2026
FY2025 Jan 3, 2025 $63.97M Mar 13, 2026
FY2025 Dec 29, 2023 $64.13M Mar 20, 2025
FY2023 Dec 30, 2022 $60.44M Mar 28, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 ($65.11M) Mar 13, 2026
FY2025 Jan 3, 2025 ($21.26M) Mar 13, 2026
FY2025 Dec 29, 2023 ($88.10M) Mar 20, 2025
FY2023 Dec 30, 2022 ($3.08M) Mar 28, 2024

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $6.37M Mar 13, 2026
FY2025 Jan 3, 2025 $10.48M Mar 13, 2026
FY2025 Dec 29, 2023 $7.04M Mar 20, 2025
FY2023 Dec 30, 2022 $10.44M Mar 28, 2024

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $218.76M Mar 13, 2026
FY2025 Jan 3, 2025 $233.86M Mar 13, 2026
FY2025 Dec 29, 2023 $426.65M Mar 20, 2025
FY2023 Dec 30, 2022 $446.80M Mar 28, 2024

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $275.40M Mar 13, 2026
FY2025 Jan 3, 2025 $268.54M Mar 13, 2026
FY2025 Dec 29, 2023 $356.16M Mar 20, 2025
FY2023 Dec 30, 2022 $395.20M Mar 28, 2024

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 ($103.80M) Mar 13, 2026
FY2025 Jan 3, 2025 ($78.21M) Mar 13, 2026
FY2025 Dec 29, 2023 $46.54M Mar 20, 2025
FY2023 Dec 30, 2022 $49.08M Mar 28, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $19.97M Mar 13, 2026
FY2025 Jan 3, 2025 $33.73M Mar 13, 2026
FY2025 Dec 29, 2023 $62.94M Mar 20, 2025
FY2023 Dec 30, 2022 $77.76M Mar 28, 2024

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 $64.46M Mar 13, 2026
FY2025 Jan 3, 2025 $9.48M Mar 13, 2026
FY2025 Dec 29, 2023 $29.63M Mar 20, 2025
FY2023 Dec 30, 2022 $0 Mar 28, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 0 Mar 13, 2026
FY2025 Jan 3, 2025 (4) Mar 13, 2026
FY2025 Dec 29, 2023 0 Mar 20, 2025
FY2023 Dec 30, 2022 0 Mar 28, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 0 Mar 13, 2026
FY2025 Jan 3, 2025 (4) Mar 13, 2026
FY2025 Dec 29, 2023 0 Mar 20, 2025
FY2023 Dec 30, 2022 0 Mar 28, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jan 2, 2026 36.04M Mar 13, 2026
FY2025 Jan 3, 2025 34.27M Mar 13, 2026
FY2025 Dec 29, 2023 25.49M Mar 20, 2025
FY2023 Dec 30, 2022 21.91M Mar 28, 2024